Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Toshie Iwai
Introduction
Toshie Iwai is a notable inventor based in Tsukuba, Japan. She has made significant contributions to the field of biochemistry, particularly in the area of cancer diagnostics. Her work has led to advancements that may improve the early detection of tumors, especially those affecting digestive organs.
Latest Patents
Toshie Iwai holds a patent for "N-Acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor." This patent describes an enzyme that transfers N-acetylglucosamine to an N-acetylgalactosaminyl group through a β1,3-linkage. The invention includes the nucleic acid coding for the enzyme and a method for diagnosing cancer and/or tumors by using the expression amount of the gene of the enzyme as an index. The enzyme was cloned from human colon and stomach cells, sequenced, and expressed, leading to the preparation of a monoclonal antibody against it. This enzyme is notably absent in cancer and/or tumor cells, making it a valuable tool for diagnosis.
Career Highlights
Toshie Iwai is affiliated with the National Institute of Advanced Industrial Science and Technology, where she continues her research and development efforts. Her innovative work has garnered attention in the scientific community, contributing to advancements in cancer diagnostics.
Collaborations
Toshie has collaborated with notable colleagues such as Hisashi Narimatsu and Niro Inaba, enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Toshie Iwai's contributions to the field of cancer diagnostics through her innovative patent demonstrate her commitment to advancing medical science. Her work has the potential to significantly improve the early detection of tumors, ultimately benefiting patient care and treatment outcomes.